Lymphoma Research Foundation (LRF): Chronic Lymphocytic Leukemia (CLL) Research Initiative

$250K over 2 years to investigate the pathogenesis, epidemiology, diagnosis or therapy of CLL or monoclonal B cell lymphocytosis (MBL).
Applications to all the initiatives above must include the study of primary FL/DLBCL/CLL/MBL patient samples to assure relevance to the human disease, and, the proposed studies should incorporate collaborative interactions between/among investigators in different disciplines (e.g. pathology & medical oncology, basic science research & clinical investigators) and/or different institutions. LRF intends to fund up to 2 applications in each of the programs.
http://www.lymphoma.org/site/pp.asp?c=bkLTKaOQLmK8E&b=6330663